Extension of the CD4⁺Foxp3⁺CD25^−/low regulatory T-cell subpopulation in type 1 diabetes mellitus

References

• Blandino-Rosano, M., G. Perez-Arana, J. M. Mellado-Gil, et al. 2008. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1. J. Mol. Endocrinol. 41: 35–44
   PubMed Web of Science ®Google Scholar
• Hamilton-Williams, E. E., S. E. Palmer, B. Charlton, and R. M. Slattery. 2003. Beta cell MHC class I is a late requirement for diabetes. Proc. Natl. Acad. Sci. 100: 6688–6693
   PubMed Web of Science ®Google Scholar
• Taborsky G. J., Jr B. Ahrén, and P. J. Havel. 1998. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes. 47: 995–1005
   PubMed Web of Science ®Google Scholar
• André, I., A. Gonzalez, B. Wang, et al. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA. 93: 2260–2263
   PubMed Web of Science ®Google Scholar
• Achenbach, P., K. Warncke, J. Reiter, et al. 2004. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes. 53: 384–392
   PubMed Web of Science ®Google Scholar
• Danke, N. A., D. M. Koelle, C. Yee, et al. 2004. Autoreactive T cells in healthy individuals. J. Immunol. Baltim. Md. 1950. 172: 5967–5972
   Google Scholar
• Hauben, E., M. G. Roncarolo, U. Nevo, and M. Schwartz. 2005. Beneficial autoimmunity in type 1 diabetes mellitus. Trends Immunol. 26: 248–253
   PubMed Web of Science ®Google Scholar
• Zóka, A., G. Műzes, A. Somogyi, et al. 2013. Altered immune regulation in type 1 diabetes. Clin. Dev. Immunol. 2013: 254874
   PubMedGoogle Scholar
• Suzuki, M., A. L. Jagger, C. Konya, et al. 2012. CD8 + CD45RA + CCR7 + FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J. Immunol. Baltim. Md. 1950 189: 2118–2130
   Google Scholar
• Curotto de Lafaille, M. A., and J. J. Lafaille. 2009. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity. 30: 626–635
   PubMed Web of Science ®Google Scholar
• Gavin, M. A., J. P. Rasmussen, J. D. Fontenot, et al. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 445: 771–775
   PubMed Web of Science ®Google Scholar
• Otsubo, K., H. Kanegane, Y. Kamachi, et al. 2011. Identification of FOXP3-negative regulatory T-like (CD4 + CD25 + CD127low) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clin. Immunol. 141: 111–120
   PubMed Web of Science ®Google Scholar
• Sun, L., J. Wu, and S. Yi. 2012. Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response. Transpl. Immunol. 26: 71–80
   PubMed Web of Science ®Google Scholar
• McMurchy, A. N., and M. K. Levings. 2013. In vitro generation of human T regulatory cells: generation, culture, and analysis of FOXP3-transduced T cells. Methods Mol. Biol. Clifton NJ. 946: 115–132
   PubMedGoogle Scholar
• Allan, S. E., S. Q. Crome, N. K. Crellin, et al. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19: 345–354
   PubMed Web of Science ®Google Scholar
• Couper, K. N., P. A. Lanthier, G. Perona-Wright, et al. 2009. Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection. J. Immunol. Baltim. Md. 1950 182: 3985–3994
   Google Scholar
• Caudy, A. A., S. T. Reddy, T. Chatila, et al. 2007. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119: 482–487
   PubMed Web of Science ®Google Scholar
• Zelenay, S., T. Lopes-Carvalho, I. Caramalho, et al. 2005. Foxp3 + CD25– CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA. 102: 4091–4096
   PubMed Web of Science ®Google Scholar
• Liu, W., A. L. Putnam, Z. Xu-Yu, et al. 2006. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203: 1701–1711
   PubMed Web of Science ®Google Scholar
• Bonelli, M., A. Savitskaya, C.-W. Steiner, et al. 2009. Phenotypic and functional analysis of CD4+CD25− Foxp3+ T cells in patients with systemic lupus erythematosus. J. Immunol. Baltim. Md. 1950 182: 1689–1695
   Google Scholar
• Prado, C., B. de Paz, P. López, et al. 2013. Relationship between FOXP3 positive populations and cytokine production in systemic lupus erythematosus. Cytokine. 61: 90–96
   PubMed Web of Science ®Google Scholar
• Fransson, M., J. Burman, C. Lindqvist, et al. 2010. T regulatory cells lacking CD25 are increased in MS during relapse. Autoimmunity 43: 590–597
   PubMed Web of Science ®Google Scholar
• De Paz, B., C. Prado, M. Alperi-López, et al. 2012. Effects of glucocorticoid treatment on CD25−FOXP3+ population and cytokine-producing cells in rheumatoid arthritis. Rheumatol. Oxf. Engl. 51: 1198–1207
   PubMed Web of Science ®Google Scholar
• Suen, J.-L., H.-T. Li, Y.-J. Jong, et al. 2009. Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology. 127: 196–205
   PubMed Web of Science ®Google Scholar
• Barnes, M. J., T. Griseri, A. M. F. Johnson, et al. 2013. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria. Mucosal Immunol. 6: 324–334
   PubMed Web of Science ®Google Scholar
• Wing, K., Y. Onishi, P. Prieto-Martin, et al. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 322: 271–275
   PubMed Web of Science ®Google Scholar
• Lühder, F., P. Höglund, J. P. Allison, et al. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187: 427–432
   PubMed Web of Science ®Google Scholar
• Long, S. A., K. Cerosaletti, P. L. Bollyky, et al. 2010. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes. 59: 407–415
   PubMed Web of Science ®Google Scholar
• Hwang, K. W., W. B. Sweatt, M. Mashayekhi, et al. 2004. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J. Immunol. Baltim. Md. 1950. 173: 5415–5424
   Google Scholar
• Downes, K., M. L. Marcovecchio, P. Clarke, et al. 2014. Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients. Diabetologia. 57: 366–372
   PubMed Web of Science ®Google Scholar
• Maier, L. M., D. E. Anderson, C. A. Severson, et al. 2009. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J. Immunol. Baltim. Md. 1950 182: 1541–1547
   Google Scholar
• Łuczyński, W., N. Wawrusiewicz-Kurylonek, A. Stasiak-Barmuta, et al. 2009. Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes. Acta Biochim. Pol. 56: 361–370
   PubMed Web of Science ®Google Scholar
• Zahran, A. M., K. I. Elsayh, and K. A. Metwalley. 2012. Regulatory T cells in children with recently diagnosed type 1 diabetes. Indian J. Endocrinol. Metab. 16: 952–957
   PubMedGoogle Scholar
• Haseda, F., A. Imagawa, Y. Murase-Mishiba, et al. 2011. Low CTLA-4 expression in CD4+ helper T-cells in patients with fulminant type 1 diabetes. Immunol. Lett. 139: 80–86
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2014. Diagnosis and classification of diabetes mellitus. Diabetes Care 37: S81–S90
   PubMed Web of Science ®Google Scholar
• Hatano, R., K. Ohnuma, J. Yamamoto, et al. 2013. CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production. Immunology 138: 165–172
   PubMed Web of Science ®Google Scholar
• Lederman, M. M., J. J. Ellner, and H. M. Rodman. 1981. Defective suppressor cell generation in juvenile onset diabetes. J. Immunol. Baltim. Md. 1950 127: 2051–2055
   Google Scholar
• Plagnol, V., J. M. M. Howson, D. J. Smyth, et al. 2011. Genome-wide association analysis of autoantibody positivity in type 1 diabetes Cases. PLoS Genet. 7: e1002216
   PubMed Web of Science ®Google Scholar
• Pociot, F., B. Akolkar, P. Concannon, et al. 2010. Genetics of type 1 diabetes: what’s next? Diabetes. 59: 1561–1571
   PubMed Web of Science ®Google Scholar
• Achenbach, P., M. Hummel, L. Thümer, et al. 2013. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia. 56: 1615–1622
   PubMed Web of Science ®Google Scholar
• Yates, J., F. Rovis, P. Mitchell, et al. 2007. The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int. Immunol. 19: 785–799
   PubMed Web of Science ®Google Scholar
• Hartemann, A., G. Bensimon, C. A. Payan, et al. 2013. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 1: 295–305
   PubMed Web of Science ®Google Scholar
• Dinesh, R., B. Hahn, and R. Singh. 2011. Sex hormones and gender influence the expression of Foxp3 and regulatory T cells in SLE patients. J. Immunol. S186: 115.18
   Google Scholar
• Salgado, F. J., A. Pérez-Díaz, N. M. Villanueva, et al. 2012. CD26: a negative selection marker for human Treg cells. Cytom. Part J. Int. Soc. Anal. Cytol. 81: 843–855
   PubMed Web of Science ®Google Scholar
• Varga, T., A. Somogyi, G. Barna, et al. 2011. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Pathol. Oncol. Res. POR. 17: 925–930
   PubMed Web of Science ®Google Scholar